VENTURELLI, ELIANA
 Distribuzione geografica
Continente #
EU - Europa 7.659
NA - Nord America 5.143
AS - Asia 2.859
SA - Sud America 298
OC - Oceania 15
AF - Africa 12
Continente sconosciuto - Info sul continente non disponibili 2
Totale 15.988
Nazione #
US - Stati Uniti d'America 4.882
GB - Regno Unito 2.646
DE - Germania 1.312
CN - Cina 1.302
SE - Svezia 826
IT - Italia 684
SG - Singapore 564
UA - Ucraina 497
RU - Federazione Russa 424
FR - Francia 334
IN - India 303
TR - Turchia 296
NL - Olanda 293
CA - Canada 249
KR - Corea 238
IE - Irlanda 202
EU - Europa 185
BR - Brasile 165
FI - Finlandia 136
PL - Polonia 130
CO - Colombia 126
GR - Grecia 68
HK - Hong Kong 37
BE - Belgio 30
DK - Danimarca 28
ID - Indonesia 24
IR - Iran 16
ES - Italia 14
JP - Giappone 12
AU - Australia 10
UZ - Uzbekistan 10
VN - Vietnam 9
ZA - Sudafrica 7
AT - Austria 6
CZ - Repubblica Ceca 6
CH - Svizzera 5
MX - Messico 5
NZ - Nuova Zelanda 5
BD - Bangladesh 4
LV - Lettonia 4
PK - Pakistan 4
SA - Arabia Saudita 4
AZ - Azerbaigian 3
IL - Israele 3
MA - Marocco 3
MY - Malesia 3
PH - Filippine 3
PT - Portogallo 3
RO - Romania 3
AE - Emirati Arabi Uniti 2
AR - Argentina 2
BA - Bosnia-Erzegovina 2
DO - Repubblica Dominicana 2
EC - Ecuador 2
EG - Egitto 2
GE - Georgia 2
IQ - Iraq 2
IS - Islanda 2
JM - Giamaica 2
KG - Kirghizistan 2
LA - Repubblica Popolare Democratica del Laos 2
LB - Libano 2
PA - Panama 2
PE - Perù 2
TH - Thailandia 2
TJ - Tagikistan 2
TW - Taiwan 2
AM - Armenia 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
CR - Costa Rica 1
EE - Estonia 1
KH - Cambogia 1
KW - Kuwait 1
KZ - Kazakistan 1
MT - Malta 1
OM - Oman 1
SK - Slovacchia (Repubblica Slovacca) 1
VE - Venezuela 1
Totale 16.171
Città #
Southend 2.395
Chandler 528
Jacksonville 430
Singapore 422
Seattle 335
Beijing 308
Frankfurt am Main 275
Princeton 275
Milan 242
Wilmington 232
Ashburn 221
Santa Clara 211
Dublin 198
Redmond 177
Ann Arbor 173
Council Bluffs 151
Nanjing 150
Somerville 150
Serra 131
Toronto 128
Warsaw 127
Mountain View 125
Bogotá 120
Sakarya 119
Andover 117
Ottawa 111
Woodbridge 108
Dearborn 101
Kent 99
Bengaluru 96
Boardman 95
Berlin 82
Des Moines 82
Athens 67
Shanghai 63
Jinan 62
Nanchang 55
New York 55
Shenyang 54
Fairfield 53
Los Angeles 43
Margão 42
Tianjin 42
Phoenix 39
Medford 34
Zhengzhou 34
Houston 33
Kiez 32
Nürnberg 31
Fuzhou 28
Hebei 28
Hangzhou 27
Cangzhou 26
Jiaxing 26
Brussels 24
Lowell 24
Quanzhou 23
Bitonto 22
Cambridge 22
Changsha 22
Verona 21
Auburn Hills 20
Hong Kong 20
Redwood City 19
Grafing 18
Lanzhou 18
Norwalk 18
Kunming 17
Odernheim 16
Palaiseau 16
Guangzhou 15
Helsinki 15
Pisa 15
San Jose 15
Taizhou 13
Haikou 12
Kwai Chung 12
Ningbo 12
San Diego 12
Sunnyvale 12
São Paulo 12
Hamburg 11
Nuremberg 10
Wuhan 10
Chicago 9
Seoul 9
The Dalles 9
Xiamen 9
Bühl 8
Hefei 8
Jakarta 8
Piscataway 8
Washington 8
Fremont 7
Newark 7
Scranton 7
Yubileyny 7
Changchun 6
Delhi 6
Falls Church 6
Totale 10.006
Nome #
NOS3 Glu298Asp polymorphism is a risk factor for frontotemporal lobar degeneration 239
The T-786C NOS3 polymorphism in Alzheimer's disease : association and influence on gene expression 237
Influence of the Glu298Asp polymorphism of NOS3 on age at aonset and homocysteine levels in AD patients 222
Rs5848 Variant Influences GRN mRNA Levels in Brain and Peripheral Mononuclear Cells in Patients with Alzheimer’s Disease 220
P-selectin glycoprotein ligand-1 variable number of tandem repeats (VNTR) polymorphism in patients with multiple sclerosis 212
Total homocysteine levels in AD patients : analysis on different onset subgroups 205
E-selectin A561C and G98T polymorphisms influence susceptibility and course of multiple sclerosis 196
Progranulin gene mutation scanning in Alzheimer's disease and frontotemporal lobar degeneration: functional and phenotypic correlations. 191
Monitoring vitamin B12 in women treated with metformin for primary prevention of breast cancer and age-related chronic diseases 190
Progranulin plasma levels as potential biomarker for the identification of GRN deletion carriers. A case with atypical onset as clinical amnestic Mild Cognitive Impairment converted to Alzheimer's disease 188
Vascular risk factors do not individually effect risk of conversion of mild cognitive impairment to dementia. 186
Novel exon 1 progranulin gene variant in Alzheimer’s disease 174
Genetic and functional analysis of progranulin gene variants in Alzheimer's disease. 171
BAG1 is a protective factor for sporadic frontotemporal lobar degeneration but not for Alzheimer's disease 170
The leukocyte expression of CD36 is low in patients with Alzheimer's disease and mild cognitive impairment 169
Progranulin gene mutation scanning in Alzheimer's disease and Frontotemporal Lobar Degeneration: fuctional and phenotypic correlations 169
Progranulin gene mutation scanning in multiple sclerosis patients with cognitive impairment 167
Association of neuronal nitric oxide synthase C276T polymorphism with Azheimer's disease 165
Neuronal Nitric Oxide Synthase C276T polymorphism increases the risk for Frontotemporal Lobar Degeneration 164
Intrathecal chemokine synthesis in mild cognitive impairment and Alzheimer disease 164
Intrathecal chemokine levels in Alzheimer disease and frontotemporal lobar degeneration 163
P-selectin glycoprotein ligand-1 variable number of tandem repeats (VNTR) polymorphism in patients with multiple sclerosis 163
Plasma levels of beta amyloid (1-42) in fronto-temporal dementia 161
Chemokine serum levels in mild cognitive impairment and Alzheimer’s disease 161
IP-10 haplotypes and multiple sclerosis : association and correlation with clinical course 161
A novel polymorphism in SEL1L confers susceptibility to Alzheimer's disease 160
Progranulin genetic variability in primary progressive multiple sclerosis. 158
Absence of mutations in TREM-2 coding region in patients with early onset dementia 157
Cerebrospinal fluid progranulin levels in patients with different multiple sclerosis subtypes 157
ApoE e2 and e4 influence the susceptibility for Alzheimer’s disease but not other dementias 156
Novel exon 1 progranulin gene variations in Alzheimer's disease and frontotemporal lobar degeneration 156
Absence of mutations in TREM-2 coding region in early onset dementia 154
Progranulin gene mutation scanning in Multiple Sclerosis patiens with cognitive impairment. 153
DCUN1D1 is a risk factor for frontotemporal lobar degeneration 153
Genetic and functional analysis of progranulin gene variants in patients with Alzheimer's disease 153
Selectin gene cluster genetic variation: association study in two independent multiple sclerosis populations. 152
Candidate gene analysis of SPARCL1 gene in patients with multiple sclerosis 151
Candidate gene analysis of semaphorins in patients with Alzheimer's disease 151
IP-10 haplotypes and multiple sclerosis : association and correlation with clinical course 149
ApoE e2 decreases the susceptibility to develop Alzheimer's disease but not frontotemporal lobar degeneration, Lewy body disease or vascular dementia 148
SELP and SELPLG single nucleotide polymorphisms in multiple sclerosis 148
GRN variability contributes to sporadic frontotemporal lobar degeneration 148
GRN rs5848 in neurodegeneration: a role in axonal damage? 146
Cell-dependent kinase inhibitor 2A and 2B genetic variability in patients with Alzheimer's disease 146
Intrathecal levels of IL-6, IL-11, LIF, and A42, tau and phosphotau biomarkers in Alzheimer’s disease and Frontotemporal Lobar Degeneration. 145
Effetto di polimorfismi genetici coinvolti nel processo infiammatorio e nel danno ossidativo nella malattia di Alzheimer 145
APOE in differents forms of MCI 145
Absence of TREM2 polymorphisms in patients with Alzheimer's disease and Frontotemporal Lobar Degeneration 145
Absence of mutations in TREM-2 coding region in early onset dementia 145
Progranulin gene variability in a population of 239 patients with primary progressive multiple sclerosis 145
Progranulin gene variability increases the risk for primary progressive multiple sclerosis in males 145
Influence of the novel M621 polymorphism in PSGL-1 gene on susceptibility and progression of Multiple Sclerosis 144
Gender-specific influence of the chromosome 16 chemokine gene cluster on the susceptibility to multiple sclerosis 143
Oxidative imbalance as potential early marker for Alzheimer’s disease 142
ApoE and family history in different forms of cognitive decline 142
Influence of the Glu298Asp polymorphism of NOS3 on age at onset and homocysteine levels in AD patients 140
Gender-specific influence of the chromosome 16 gene cluster on the susceptibility to multiple sclerosis 137
CCR2-64I polymorphism and CCR5Delta32 deletion in patients with Alzheimer's disease 137
Progranulin gene mutation scanning and expression analysis in patients with Alzheimer's disease 137
Genetic and functional analysis of progranulin gene variants in Alzheimer's disease 137
Chemokine serum levels in mild cognitive impairment and Alzheimer’s disease 136
CSF levels of IL-6, IL-11, LIF, A42, TAU and phospoTAU biomarkers in Alzheimer’s disease and Frontotemporal Lobar Degeneration 135
SELPLG and SELP single-nucleotide polymorphisms in multiple sclerosis 135
rs 5848 variant influences GRN mRNA levels in brain and peripheral mononuclear cells from patients with Alzheimer's disease 134
The T-786C NOS3 polymorphism in Alzheimer's disease : association and influence on gene expression 134
MCP-1 A-2518G polymorphism: effect on sysceptibility for Frontotemporel Lobar Degeneration and on cerebrospina fluid MCP-1 levels. 134
MDC/CCL22 intrathecal levels in patients with multiple sclerosis 134
CXCL10 haplotypes and multiple sclerosis : association and correlation with clinical course 133
CDKN2A and CDKN2B genetic variability in Alzheimer's disease patients. 133
CHMP5 and BAG1 are protective factors for sporadic frontotemporal lobar degeneration 133
P-selectin (SELP) and P-selectin glicoprotein ligand-1 (SELPLG)polymorphisms in multiple sclerosis patients 132
The MCP-1 A-2518G polymorphism acts as proctective factor for frontotemporal lobar degeneration 132
Selectin gene cluster genetic variation: association study in two independent multiple sclerosis populations. 131
Cerebrospinal fluid biomarkers for Alzheimer's disease 130
Expression profile of miRNAs involved in CD4+ lymphocyte activation and differentiation in patients with multiple sclerosis 130
The NOS G894T (Glu298Asp) polymorphism is a risk for frontotemporal lobar degeneration 129
PGRN polymorphisms influence the susceptibility for Alzheimer’s disease 127
Gender-specific influence of the chromosome 16 chemokine gene cluster on the susceptibility to multiple sclerosis 126
Progranulin gene mutation scanning in Italian Alzheimer's disease population 124
Gender-specific influence of the chromosome 16 chemokine genecluster on the susceptibility to Multiple Sclerosis 124
The locus 387715 in Alzheimer’s disease 123
Sintesi intratecale di chemochine nel decadimento cognitivo lieve e nella Malattia di Alzheimer 123
GRN rs5848 polymorphism: a role in neurodegeneration? 123
Serum MCP-1 levels are increased in mild cognitive impairment and mild Alzheimer's disease 122
Is KIF24 a genetic risk factor for Frontotemporal Lobar degeneration? 122
Neuronal nitric oxide synthase C276T polymorphism increases the risk for Frontotemporal Lobar Degeneration 121
Novel exon 1 progranulin gene variant in Alzheimer's disease. 121
The T-786C polymorphism in Alzheimer's disease : association and influence on gene expression 120
Neuronal nitric oxide synthase C276T polymorphism increases the risk for frontotemporal lobar degeneration 119
PGRN genetic variability in Alzheimer's disease: effect on susceptibility, age at onset and mRNS levels 119
Chemokine serum levels in mild cognitive impairment and Alzheimer’s disease 118
Gender-specific influence of the chromosome 16 chemokine gene cluster on the susceptibility to multiple sclerosis 118
Prevalence of ApoE-e2 allele in different kinds of dementia 117
Analysis of the prevalence of behavioural and psychiatric disorders among Alzheimer's disease patients with and without PLAU1 polymorphism. 117
rs5848 variant influences GRN mRNA levels in patients with Alzheimer's Disease. 116
MCP-1 A-2518G polymorphism : effect on susceptibility for frontotemporal lobar degeneration and on cerebrospinal fluid MCP-1 levels 115
Chemokine serum levels in mild cognitive impairment as Alzheimer's disease early biomarkers 115
The MCP-1 A-2518G polymorphism acts as protective factor for frontotemporal lobar degeneration 115
MCP-1 A-2518G polymorphism : effect on susceptibility for Frontotemporal Lobar Degeneration and on cerebrospinal fluid MCP-1 level 114
CXCL10 haplotypes and multiple sclerosis : association and correlation with clinical course 113
Totale 14.775
Categoria #
all - tutte 51.855
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 51.855


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020160 0 0 0 0 0 0 0 0 0 0 122 38
2020/20211.822 88 201 193 5 168 104 115 65 208 112 451 112
2021/20221.136 79 29 13 37 71 33 156 32 183 129 105 269
2022/20231.796 234 219 138 196 236 350 43 110 202 7 41 20
2023/20241.222 24 91 49 64 445 71 45 51 36 113 109 124
2024/20251.976 105 249 33 355 325 79 34 275 140 330 51 0
Totale 16.948